A Blueprint for Helping Children with Rare Diseases
The U.S. Congress and the Food and Drug Administration have long focused on bringing new therapies to patients with rare diseases, including children.
Read MoreKeeping You Informed: An Update on FDA’s Judicious Use Strategy for Antimicrobial Drugs in Food-Producing Animals
Today, “antibiotic resistance” is a widely recognized concern. With the rise of bacteria that are resistant to many, and in some cases, all standard treatments, scientists and medical professionals are not alone in focusing on this problem.
Read MoreFDA Refines Its Thinking on Nanotechnology
FDA finalized three guidance documents that address various aspects of the use of nanotechnology in products regulated by the agency
Read More10 Shocking Medical Mistakes
When you’re a patient, you trust you’re in good hands, but even the best doctor or nurse can make a mistake on you or someone you love.
Read MoreSleep centers provide lessons for need to adapt in changing health system
Sleep centers provide lessons for need to adapt in changing health system
Read MoreFirst pill to prevent HIV is only for some patients
Physicians applaud the latest step in reducing new HIV cases, but insist that high-risk individuals who take the medication still need to practice safe sex.
Read MoreNews
Top Five Trends Changing the Game in Global Healthcare IT
stethoscope in two years, preferring to examine his patients with a handheld ultrasound unit to view a patient’s heart in real-time. In 2012 alone, physicians in the U.S. are expected to increase their use of smartphones and tablets by 81 per cent.
Strategy
Global Licensing & Registration
Drug product registration and licensing in Europe, Africa, Asia, the Middle East and South America
Strategy
Global Drug & Medical Device Regulatory Consulting
Global Licensing and Registration, Product Registration Process – a strategy that ensures optimum results, Dossier Preparation for Export and Registration, Writing & Review of- Summaries and Drug Master File